Maria Augusta Bento Cicaroni Gibelli

Maria Augusta Bento Cicaroni Gibelli

Auto-generated profile, based on publicly available information

Maria Augusta Bento Cicaroni Gibelli

Departamento de Pediatria da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Clinics
Verified
Journal Article
Open access
MPMaria Fernanda Badue Pereira
Maria Fernanda Badue Pereira
NLNadia Litvinov
Nadia Litvinov
SFSylvia Costa Lima Farhat
Sylvia Costa Lima Farhat
AEAdriana Pasmanik Eisencraft
Adriana Pasmanik Eisencraft
MGMaria Augusta Bento Cicaroni Gibelli
Maria Augusta Bento Cicaroni Gibelli
PJPatricia Palmeira Daenekas Jorge
Patricia Palmeira Daenekas Jorge
To assess the outcomes of pediatric patients with laboratory-confirmed coronavirus disease (COVID-19) with or without multisystem inflammatory syndrome in children (MIS-C).This cross-sectional study included 471 samples collected from 371 patients (age<18 ...

1 September 2020 in Palliative and Supportive Care
Verified
Journal Article
Closed access
PDF file
MSM.S. Setubal
M.S. Setubal
RBR. Bolibio
R. Bolibio
RJR.C. Jesus
R.C. Jesus
GBG.G. Benute
G.G. Benute
MGM.A. Gibelli
M.A. Gibelli
LBL. Stein Bernardes
L. Stein Bernardes
Objective: Expectant parents who live through perinatal loss experience intense grief, which is not always acknowledged or accepted. A screening tool to detect bereaved parents’ grief reactions can guide professionals, including perinatal palliative care teams, to provide follow-up for those in need. This review's goal is to identify and synthesize the international published literature on existent instruments specifically measuring the grieving process after any perinatal loss and to identify factors that could moderate grief reactions.Method: Systematic review (PROSPERO # CRD42018092555) with critical synthesis. PUBMED, Cochrane, and PsycINFO databases were searched in English language articles using the keywords “perinatal” AND (“grief” OR “bereavement” OR mourning) AND (“scale” OR “questionnaire” OR “measure” OR “assessment”) up to May 2018. Eligibility criteria included every study using a measure to assess perinatal grief after all kinds of perinatal losses, including validations and translations to other languages and interventions designed to alleviate grief symptoms.Results: A total of 67 papers met inclusion criteria. Seven instruments measuring perinatal grief published between 1984 and 2002 are described. The Perinatal Grief Scale (PGS) was used in 53 of the selected studies. Of those, 39 analyzed factors associated with grief reactions. Six articles used PGS scores to evaluate pre- and post-bereavement interventions. Studies in English language only might have limited the number of articles.Significance of results: The PGS is the most used standardized measures to assess grief after perinatal loss. All parents living through any kind of perinatal loss should be screened.

1 January 2020 in Clinics
Verified
Journal Article
Open access
PDF file
WCWerther Brunow de Carvalho
Werther Brunow de Carvalho
MGMaria Augusta Bento Cicaroni Gibelli
Maria Augusta Bento Cicaroni Gibelli
VKVera Lúcia Jornada Krebs
Vera Lúcia Jornada Krebs
VCValdenise Martins Laurindo Tuma Calil
Valdenise Martins Laurindo Tuma Calil
CJCíntia Johnston
Cíntia Johnston
This article presents expert recommendations for assisting newborn children of mothers with suspected or diagnosed coronavirus disease 2019 (COVID-19). The consensus was developed by five experts with an average of 20 years of experience in neonatal intensive care working at a reference university hospital in Brazil for the care of pregnant women and newborns with suspected or confirmed COVID-19. Despite the lack of scientific evidence regarding the potential for viral transmission to their fetus in pregnant mothers diagnosed with or [...] This article presents expert recommendations for assisting newborn children of mothers with suspected or diagnosed coronavirus disease 2019 (COVID-19). The consensus was developed by five experts with an average of 20 years of experience in neonatal intensive care working at a reference university hospital in Brazil for the care of pregnant women and newborns with suspected or confirmed COVID-19. Despite the lack of scientific evidence regarding the potential for viral transmission to their fetus in pregnant mothers diagnosed with or

15 June 2018 in Revista de Medicina
Verified
Journal Article
Open access
PDF file
RBRenata Bolibio
Renata Bolibio
RJRoberta Carolina De Almeida Jesus
Roberta Carolina De Almeida Jesus
FOFernanda Figueiredo de Oliveira
Fernanda Figueiredo de Oliveira
MGMaria Augusta Bento Cicaroni Gibelli
Maria Augusta Bento Cicaroni Gibelli
GBGlaucia Rosana Guerra Benute
Glaucia Rosana Guerra Benute
LBLisandra Stein Bernardes
Lisandra Stein Bernardes
Malformações fetais acometem cerca de 3% das gestações, e a possibilidade desse diagnóstico é uma das principais preocupações vivenciadas pelos pais e familiares. Quando é diagnosticado uma malformação que implique em possível mortalidade da criança, é necessário o planejamento do seguimento da gestação, o que abrange diversos aspectos que incluem avaliação minuciosa do prognóstico, organização do cuidado após o parto, e seguimento da família de forma abrangente e integrada. Recentemente os conceitos de cuidados paliativos foram introduzidos na perinatologia com essa finalidade, e o presente artigo tem como objetivo discutir o modelo de cuidado paliativo aplicado no atendimento a gestantes e familiares de fetos com malformação.

1 January 2020 in Clinics
Verified
Journal Article
Open access
WCWerther Brunow de Carvalho
Werther Brunow de Carvalho
MGMaria Augusta Cicaroni Gibelli
Maria Augusta Cicaroni Gibelli
VKVera Lúcia Jornada Krebs
Vera Lúcia Jornada Krebs
VCValdenise Martins Laurindo Tuma Calil
Valdenise Martins Laurindo Tuma Calil
CNCarla Marques Nicolau
Carla Marques Nicolau
CJCíntia Johnston
Cíntia Johnston

17 November 2021 in Clinics
Verified
Journal Article
Open access
HMHeloisa Helena de Sousa Marques
Heloisa Helena de Sousa Marques
MPMaria Fernanda Badue Pereira
Maria Fernanda Badue Pereira
ASAngelica Carreira dos Santos
Angelica Carreira dos Santos
TFThais Toledo Fink
Thais Toledo Fink
CPCamila Sanson Yoshino de Paula
Camila Sanson Yoshino de Paula
HGHC-FMUSP Pediatric COVID Study Group
HC-FMUSP Pediatric COVID Study Group
To compare demographic/clinical/laboratory/treatments and outcomes among children and adolescents with laboratory-confirmed coronavirus disease 2019 (COVID-19). This was a cross-sectional study that included patients diagnosed with pediatric COVID-19 (aged <18 years) between April 11, 2020 and April 22, 2021. During this period, 102/5,951 (1.7%) of all admissions occurred in neonates, children, and adolescents. Furthermore, 3,962 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection samples were processed in patients aged <18 years, and laboratory-confirmed COVID-19 occurred in 155 (4%) inpatients and outpatients. Six/155 pediatric patients were excluded from the study. Therefore, the final group included 149 children and adolescents (n=97 inpatients and 52 outpatients) with positive SARS-CoV-2 results. The frequencies of sore throat, anosmia, dysgeusia, headache, myalgia, nausea, lymphopenia, pre-existing chronic conditions, immunosuppressive conditions, and autoimmune diseases were significantly reduced in children and adolescents (p<0.05). Likewise, the frequencies of enoxaparin use (p=0.037), current immunosuppressant use (p=0.008), vasoactive agents (p=0.045), arterial hypotension (p<0.001), and shock (p=0.024) were significantly lower in children than in adolescents. Logistic regression analysis showed that adolescents with laboratory-confirmed COVID-19 had increased odds ratios (ORs) for sore throat (OR 13.054; 95% confidence interval [CI] 2.750-61.977; p=0.001), nausea (OR 8.875; 95% CI 1.660-47.446; p=0.011), and lymphopenia (OR 3.575; 95% CI 1.355-9.430; p=0.010), but also had less hospitalizations (OR 0.355; 95% CI 0.138-0.916; p=0.032). The additional logistic regression analysis on patients with preexisting chronic conditions (n=108) showed that death as an outcome was significantly associated with pediatric severe acute respiratory syndrome (SARS) (OR 22.300; 95% CI 2.341-212.421; p=0.007) and multisystem inflammatory syndrome in children (MIS-C) (OR 11.261; 95% CI 1.189-106. 581; p=0.035). Half of the laboratory-confirmed COVID-19 cases occurred in adolescents. Individuals belonging to this age group had an acute systemic involvement of SARS-CoV-2 infection. Pediatric SARS and MIS-C were the most important factors associated with the mortality rate in pediatric chronic conditions with COVID-19.